PDB39 EVALUATION OF THE COST-UTILITY OF INSULIN DETEMIR COMPARED TO INSULIN GLARGINE, BOTH IN COMBINATION WITH INSULIN ASPART INTYPE-I DIABETES IN GERMANY AND AUSTRIA
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67658-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67658-9/fulltext
Title :
PDB39 EVALUATION OF THE COST-UTILITY OF INSULIN DETEMIR COMPARED TO INSULIN GLARGINE, BOTH IN COMBINATION WITH INSULIN ASPART INTYPE-I DIABETES IN GERMANY AND AUSTRIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67658-9&doi=10.1016/S1098-3015(10)67658-9
First page :
Section Title :
Open access? :
No
Section Order :
239